Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMNIMARA Trial
2011-002684-25Phase 2Active
- Sponsor
- Antwerp University Hospital
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Idiopathic Short Stature (ISS) comparing Omnitrope monotherapy, Femara monotherapy and Omnitrope + Femara combination therapy (3 arms). Primary endpoint: Adult height gain. Started Mar 2012; status: active.
02
Drugs
somatropinletrozole
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on 2011-002684-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002684-25.